TT  Innovate Indiana Fund

     Office Locations:

351 W. 10th Street
Indianapolis, IN 46202



  • Early
  • Seed



  • Information Technology
  • Life Sciences & Healthcare



    To harness Indiana University's creativity and to strengthen Indiana's economy, IU created the $10 million Innovate Indiana Fund. The fund provides equity capital for company formation and to support these new ventures at early stages, when funding is most difficult to obtain. This evergreen fund--available to individuals with an IU connection-- provides seed capital to start, nurture, and grow technology start-ups, giving faculty and entrepreneurs a new resource for the support they need. Prior to funding, the Innovate Indiana Fund will coordinate with the founders/company to identify and agree upon the commercialization strategy and specific R&D milestones to ensure that a clear road map is articulated at the earliest stages. Pre-seed investments are funds dedicated to technologies that are on a defined development path or that seek to answer a very specific commercial question. Seed investments support product finalization, customer acquisition, and activities for scaling up your start-up business.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Brian Anderson Analyst
    Ken Green Managing Director


    Recent Funding Events (trailing 12 months):












    Portfolio companies include:

      Aarden Pharmaceuticals
        web link

        web link

      ApeX Therapeutics
        web link

        web link

        web link


    Recent News: